# Biomarker-enhanced ED Disposition Decisions

> **NCT00920491** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 400 (actual)

## Conditions studied

- Non-specific Complaints

## Interventions

- **BIOLOGICAL:** biomarker-enhanced disposition decision with proADM

## Key facts

- **NCT ID:** NCT00920491
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2014-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920491, "Biomarker-enhanced ED Disposition Decisions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00920491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*